Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized COVID patients … COVID antiviral pill trials move forward, long-term care component added … Interactive tool helps find your place in line for…
The Mediterranean diet reduces diabetes risk by 30% in women who are considered clinically overweight or obese, a new analysis of long-term data finds.
A few pounds of weight loss nearly halves diabetes risk, large-scale study finds … FDA: Only N95s are nearly 100% effective, but cloth masks also protective … Link between gut microbiome and risk of Alzheimer’s brain plaques confirmed … Long-term study finds walnut consumption may reduce heart disease risk … Heart failure drug succeeds in…
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical trial.
A study involving hundreds of Veterans Affairs patients shows a link between the diabetes drug metformin and a lower risk of death from COVID-19.
Nursing homes residents who use continuous glucose monitors (CGMs) to track their daily blood sugar levels would see their Medicare coverage and payments for the devices expanded under a new proposed rule by the federal government. The Centers for Medicare & Medicaid Services on Tuesday announced a proposal for several new changes to Medicare Durable…
The diseases are independent risk factors for dying from COVID-19, according to a nationwide analysis in England (diabetes) and a large study in the U.S. (Parkinson’s)
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.
Vitamin D treatment in adults with low levels but no symptoms of deficiency has no effect on most health outcomes, including fractures, depression and diabetes, a new analysis shows.
A large new study finds that people with type 2 diabetes have a 36% higher risk for vascular dementia when compared with people who do not have diabetes.
